These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 233695)

  • 21. Hereditary resistance to 1,25-dihydroxyvitamin D: clinical and radiological improvement during high-dose oral calcium therapy.
    Sakati N; Woodhouse NJ; Niles N; Harfi H; de Grange DA; Marx S
    Horm Res; 1986; 24(4):280-7. PubMed ID: 3023230
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term intracaval calcium infusion therapy in end-organ resistance to 1,25-dihydroxyvitamin D.
    Weisman Y; Bab I; Gazit D; Spirer Z; Jaffe M; Hochberg Z
    Am J Med; 1987 Nov; 83(5):984-90. PubMed ID: 2823606
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vitamin-D-dependent rickets type II. Resistance of target organs to 1,25-dihydroxyvitamin D.
    Brooks MH; Bell NH; Love L; Stern PH; Orfei E; Queener SF; Hamstra AJ; DeLuca HF
    N Engl J Med; 1978 May; 298(18):996-9. PubMed ID: 205789
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vitamin D and vitamin D dependency.
    Tsuchiya Y; Matsuo N; Cho H; Tsubouchi K; Kumagai M; Nishii Y; Nanjoh M; Yamamoto T
    Contrib Nephrol; 1980; 22():89-100. PubMed ID: 6967387
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Vitamin D and its therapeutic use].
    Fournier A; Sebert JL; Boudailliez B; Morinière P
    Ann Med Interne (Paris); 1985; 136(2):164-79. PubMed ID: 3000252
    [No Abstract]   [Full Text] [Related]  

  • 26. The vitamin D receptor and the syndrome of hereditary 1,25-dihydroxyvitamin D-resistant rickets.
    Malloy PJ; Pike JW; Feldman D
    Endocr Rev; 1999 Apr; 20(2):156-88. PubMed ID: 10204116
    [No Abstract]   [Full Text] [Related]  

  • 27. 1,25-dihydroxyvitamin D3 and 1, alpha-hydroxyvitamin D3 in children: biologic and therapeutic effects in nutritional rickets and different types of vitamin D resistance.
    Balsan S; Garabedian M; Sorgniard R; Holick MF; Deluca HF
    Pediatr Res; 1975 Jul; 9(7):586-93. PubMed ID: 169507
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 25-Hydroxycholecalciferol. A comparative study in deficiency rickets and different types of resistant rickets.
    Balsan S; Garabedian M
    J Clin Invest; 1972 Apr; 51(4):749-59. PubMed ID: 4335443
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Hypocalcemic vitamin D-dependent renal rickets].
    Velásquez Jones L; Arrocha Arrocha E; Rafael Chaparro A; De Almeida-Rego ilho E; Gordillo Paniagua G
    Bol Med Hosp Infant Mex; 1976; 33(6):1217-27. PubMed ID: 188433
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Two siblings with vitamin-D-dependent rickets type II: no recurrence of rickets for 14 years after cessation of therapy.
    Takeda E; Yokota I; Kawakami I; Hashimoto T; Kuroda Y; Arase S
    Eur J Pediatr; 1989 Oct; 149(1):54-7. PubMed ID: 2558018
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vitamin D metabolism and osteomalacia in cystic fibrosis.
    Friedman HZ; Langman CB; Favus MJ
    Gastroenterology; 1985 Mar; 88(3):808-13. PubMed ID: 3871414
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Healing of bone lesions with 1,25-dihydroxyvitamin D3 in the young X-linked hypophosphatemic male mouse.
    Marie PJ; Travers R; Glorieux FH
    Endocrinology; 1982 Sep; 111(3):904-11. PubMed ID: 6896684
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Vitamin D-resistant rickets type II: apropos of 2 cases].
    Simonin G; Chabrol B; Moulene E; Bollini G; Strouc S; Mattei JF; Giraud F
    Pediatrie; 1992; 47(12):817-20. PubMed ID: 1338926
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rickets and alopecia with resistance to 1,25-dihydroxyvitamin D: two different clinical courses with two different cellular defects.
    Balsan S; Garabedian M; Liberman UA; Eil C; Bourdeau A; Guillozo H; Grimberg R; Le Deunff MJ; Lieberherr M; Guimbaud P; Broyer M; Marx SJ
    J Clin Endocrinol Metab; 1983 Oct; 57(4):803-11. PubMed ID: 6309886
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of prolonged treatment with 25-hydroxycholecalciferol in hypophosphatemic (vitamin D refractory) rickets and osteomalacia.
    Cohanim M; DeLuca HF; Yendt ER
    Johns Hopkins Med J; 1972 Aug; 131(2):118-32. PubMed ID: 4340527
    [No Abstract]   [Full Text] [Related]  

  • 36. Vitamin D metabolism in biliary atresia: intestinal absorptions of 25-hydroxyvitamin D3 and 1,25-dihydroxyvitamin D3.
    Kimura S; Seino Y; Harada T; Nose O; Yamaoka K; Shimizu K; Tanaka H; Yabuuchi H; Fukui Y; Kamata S
    J Pediatr Gastroenterol Nutr; 1988; 7(3):341-6. PubMed ID: 3260278
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of 1,25-dihydroxyvitamin D in the mechanism of acquired vitamin D deficiency.
    Clements MR; Davies M; Hayes ME; Hickey CD; Lumb GA; Mawer EB; Adams PH
    Clin Endocrinol (Oxf); 1992 Jul; 37(1):17-27. PubMed ID: 1424188
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An unique form of osteomalacia associated with end organ refractoriness to 1,25-dihydroxyvitamin D and apparent defective synthesis of 25-hydroxyvitamin D.
    Zerwekh JE; Glass K; Jowsey J; Pak CY
    J Clin Endocrinol Metab; 1979 Aug; 49(2):171-5. PubMed ID: 313402
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Osteomalacia in hereditary hypophosphatemic rickets with hypercalciuria: a correlative clinical-histomorphometric study.
    Gazit D; Tieder M; Liberman UA; Passi-Even L; Bab IA
    J Clin Endocrinol Metab; 1991 Jan; 72(1):229-35. PubMed ID: 1986023
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 1alpha-hydroxyvitamin D3 in the treatment of nutritional and metabolic rickets and osteomalacia.
    Gertner JM; Brenton DB; Edwards RH
    Clin Endocrinol (Oxf); 1977 Dec; 7 Suppl():239s-244s. PubMed ID: 203419
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.